Highbridge Capital Management’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-20,344
Closed -$382K 1196
2017
Q1
$382K Buy
+20,344
New +$320K 0.01% 1025
2016
Q3
Sell
-21,377
Closed -$230K 1272
2016
Q2
$230K Buy
+21,377
New +$229K ﹤0.01% 1181
2015
Q3
Sell
-15,952
Closed -$189K 1487
2015
Q2
$189K Buy
15,952
+6,945
+77% +$80.5K ﹤0.01% 1300
2015
Q1
$85K Buy
+9,007
New +$93.1K ﹤0.01% 1323

Other funds holding ACLS

Highbridge Capital Management's ACLS Position: Q2 2017 in Review

Highbridge Capital Management sold out of Axcelis (ACLS) in Q2 2017, closing a stake of 20,344 shares — an estimated $382K sold.

Highbridge Capital Management first reported a position in ACLS in Q1 2015 and held it in 4 quarters. The position peaked at $382K in Q1 2017. 130 funds tracked by Wall St. Rank hold ACLS as of Q2 2017.

  • Highbridge Capital Management reported no remaining Axcelis position as of Q2 2017 after selling out during the quarter.
  • Highbridge Capital Management sold 20,344 Axcelis shares in Q2 2017, an estimated $382K.
  • Highbridge Capital Management first reported a position in Axcelis in Q1 2015 and held it in 4 quarters.
  • Highbridge Capital Management's Axcelis position peaked at $382K in Q1 2017.
  • 130 funds tracked by Wall St. Rank held Axcelis as of Q2 2017.

Based on Highbridge Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.